MedTrace Logo

Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients

NCT06849011 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1185

Last updated 2025-02-27

No results posted yet for this study

Summary

The study aims to develop and validate a prognostic prediction model for adverse outcomes in neurocritical patients receiving enteral nutrition based on key inflammatory and metabolic markers. This model will serve as a clinical tool to help physicians identify high-risk patients and guide individualized nutritional support strategies.

Conditions

Sponsors & Collaborators

  • Yan Zhang

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06849011 on ClinicalTrials.gov